Novel compound Ovataline isolated from Ostreopsis cf. ovata and composition for preventing, improving or treating benign prostatic hyperplasia comprising the same as an effective ingredient

摘要

The present invention relates to obatalin represented by the following formula (1). Thereby, it can replace finasteride or dutasteride, polarity, well soluble in water, can be extracted from natural ingredients, and 5AR2 (5α-reductase type 2) in RWPE-1 cells of the prostate ), it is possible to effectively treat benign prostatic hyperplasia by suppressing the expression. [Formula 1]